Skip to main content

Table 1 Patient and disease characteristics of 46 patients with paranasal sinus carcinomas treated with IMRT

From: Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes

  N (%)
Gender  
female 18 (39%)
male 28 (61%)
Histology  
Adenocarcinoma 8 (17.4%)
Squamous Cell Carcinoma 6 (13%)
Adenoid-cystic Carcinoma 20 (43.4%)
Melanoma 8 (17.4%)
other 4 (8.8%)
Primary tumor site  
Maxillary sinus 22 (47.8%)
Ethmoidal sinus 4 (8.7%)
Sphenoid sinus 4 (8.7%)
Nasal cavity 16 (34.8%)
Tumor stage  
T1 2 (4%)
T2 3 (7%)
T3 11 (24%)
T4 30 (65%)
Nodal stage  
N0 34 (74%)
N1 6 (13%)
N2 1 (2%)
Nx 5 (11%)